Similarly, studies have demonstrated that dexmedetomidine has a protective effect on LPS-induced ALI in vitro and in vivo, possibly by inhibiting inflammatory responses through HMGB1-mediated TLR4/NF-κB and PI3K/AKT/mTOR pathways [51]. Here, NFKB1 is linked to acute respiratory distress syndrome.